Cardiology
Editorial Comment
Paravalvular Regurgitation after Transcutaneous Aortic Valve Replacement: A Dynamic Lesion?Pressman G.S.Einstein Medical Center, Philadelphia, PA, USA
|
|
Cardiology 2017;137:25-26
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication Details
Received: November 29, 2016
Accepted: November 29, 2016
Published online: December 16, 2016
Issue release date: April 2017
Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0
ISSN: 0008-6312 (Print)
eISSN: 1421-9751 (Online)
For additional information: https://www.karger.com/CRD
First-Page Preview
Related Articles:
References
- Shibayama K, Mihara H, Jilaihawi H, Berdejo J, Harada K, Itabashi Y, Siegel R, Makkar RR, Shiota T: 3D assessment of features associated with transvalvular aortic regurgitation after TAVR: a real-time 3D TEE study. JACC Cardiovasc Imaging 2016;9:114-123.
- Kiramijyan S, Magalhaes MA, Koifman E, Didier R, Escarcega RO, Baker NC, Negi SI, Minha S, Torguson R, Jiaxiang G, Asch FM, Wang Z, Okubagzi P, Gaglia MA Jr, Ben-Dor I, Satler LF, Pichard AD, Waksman R: Aortic regurgitation in patients undergoing transcatheter aortic valve replacement with the self-expanding CoreValve versus the balloon-expandable Sapien XT valve. Am J Cardiol 2016;117:1502-1510.
- Pibarot P, Hahn RT, Weissman NJ, Monaghan MJ: Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme. JACC Cardiovasc Imaging 2015;8:340-360.
- Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB, PARTNER Trial Investigators: Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366:1686-1695.
- Kodali S, Pibarot P, Douglas PS, Williams M, Xu K, Thourani V, Rihal CS, Zajarias A, Doshi D, Davidson M, Tuzcu EM, Stewart W, Weissman NJ, Svensson L, Greason K, Maniar H, Mack M, Anwaruddin S, Leon MB, Hahn RT: Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards Sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J 2015;36:449-456.
- Goncalves A, Nyman C, Okada DR, Singh A, Swanson J, Cheezum M, Steigner M, Di Carli M, Solomon S, Shah PB, Bhatt DL, Shook D, Blankstein R: Transthoracic echocardiography to assess aortic regurgitation after TAVR: a comparison with periprocedural transesophageal echocardiography. Cardiology 2017;137:1-8.
- Jilaihawi H, Chakravarty T, Shiota T, Rafique A, Harada K, Shibayama K, Doctor N, Kashif M, Nakamura M, Mirocha J, Rami T, Okuyama K, Cheng W, Sadruddin O, Siegel R, Makkar RR: Heart-rate adjustment of transcatheter haemodynamics improves the prognostic evaluation of paravalvular regurgitation after transcatheter aortic valve implantation. EuroIntervention 2015;11:456-464.
Article / Publication Details
Received: November 29, 2016
Accepted: November 29, 2016
Published online: December 16, 2016
Issue release date: April 2017
Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0
ISSN: 0008-6312 (Print)
eISSN: 1421-9751 (Online)
For additional information: https://www.karger.com/CRD
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
